Skip to main content

Table 3 Results of the cost-effectiveness analysis of the strategies “RP”, “CS-G6PD” and “BX-G6PD”, according to the outcomes assessed in the Brazilian Amazon, 2013

From: Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon

Strategy

Effectiveness

Incremental effectiveness

Cost (US$)

Incremental cost (US$)

ICER (US$)

Outcome: adequately diagnosed case

 RP

0

11.270

 BX-G6PD (vs. RP)

0.0135

0.0135

11.404

0.134

9.96

 CS-G6PD (vs. RP)

0.0716

0.0716

11.578

0.308

4.30

 CS-G6PD (vs. BX-G6PD)

0.0716

0.0581

11.578

0.174

2.99

Outcome: hospitalization avoided

 

 CS-G6PD

0.0723

12.078

Dominant

 BX-G6PD (vs. CS-G6PD)

0.0712

−0.0010

12.200

0.122

Dominated

 RP (vs. CS-G6PD)

0.0708

−0.0014

12.175

0.097

Dominated

 BX-G6PD (vs. RP)

0.0712

0.0004

12.200

0.025

63.92